Metastatic melanoma is the most deadly skin neoplasm in the United States.
Outcomes for this lethal disease have improved dramatically due to the use of both targeted and immunostimulatory drugs.
Immunogenic cell death (ICD) has emerged as another approach for initiating antitumor immunity.
